Evarrest

From WikiMD's Food, Medicine & Wellness Encyclopedia

What is Evarrest[edit | edit source]


What are the uses of this medicine?[edit | edit source]

  • EVARREST® is a fibrin sealant patch indicated for use with manual compression as an adjunct to hemostasis in adult patients undergoing surgery, when control of bleeding by conventional surgical techniques (such as suture, ligature, and cautery) is ineffective or impractical.

Limitations for Use:

  • Cannot be used in place of sutures or other forms of mechanical ligation in the treatment of major arterial or venous bleeding.
  • Not for use in children under one month of age
  • Laparoscopic and other minimally invasive surgeries where manual compression would be difficult to achieve.

How does this medicine work?[edit | edit source]

  • The mechanism of action of EVARREST is based on the interaction between the biological components and the physiology of the fibrin clot formation.
  • Upon contact with a bleeding wound surface, the biological components embedded in the patch component are hydrated, and the subsequent fibrinogen-thrombin reaction initiates the last step in the cascade of biochemical reactions - conversion of fibrinogen into fibrin monomers that further polymerize to form the fibrin clot.
  • Hemostasis is achieved when the formed fibrin clot integrates with the patch component and adheres to the wound surface thus also providing a physical barrier to bleeding.

Who Should Not Use this medicine ?[edit | edit source]

This medicine cannot be used for:

  • Bleeding from large defects in visible arteries or veins.
  • Intravascular application
  • Individuals known to have anaphylactic or severe systemic reaction to human blood products

What drug interactions can this medicine cause?[edit | edit source]

  • No formal drug interaction studies have been conducted with EVARREST.

Is this medicine FDA approved?[edit | edit source]

  • Initial U.S. Approval: 2012

How should this medicine be used?[edit | edit source]

Recommended dosage:

  • Determine the number of patches to be applied based upon the surface area and anatomic location of the bleeding to be treated.
  • Do not use more than eight 2 × 4 inch (5.1 × 10.2 cm) patches.

Administration:

  • Keep the patch dry until use.
  • Place the powdery (active) side of the patch on the surface of tissue.
  • Apply immediate manual compression over the entire surface of the patch and maintain contact pressure for 3 minutes to control the bleeding.

What are the dosage forms and brand names of this medicine?[edit | edit source]

This medicine is available in fallowing doasage form:

  • As 2 × 4 inch (5.1 × 10.2 cm) absorbable patch contains
  • 55.5 mg per square inch (8.6 mg per square cm) human fibrinogen
  • 241.9 Units per square inch (37.5 Units per square cm) human thrombin

This medicine is available in fallowing brand namesː

  • EVARREST

What side effects can this medication cause?[edit | edit source]

The most common side effects of this medicine include:

What special precautions should I follow?[edit | edit source]

  • Thrombosis can occur if absorbed systemically. Apply topically to the bleeding site only.
  • EVARREST Can cause hypersensitivity reactions including anaphylaxis.
  • Avoid application to contaminated areas of the body or in the presence of active infection. Infection can occur.
  • EVARREST® contains oxidized regenerated cellulose which adheres to bleeding surfaces. Inadvertent adhesions can occur.
  • Avoid use in, around, or in proximity to, foramina in bone or areas of bony confine where swelling may cause compression.
  • Use the least number of patches required to cover the entire bleeding area.
  • Because the biological components of this product are made from human plasma, it may carry a risk of transmitting infectious agents, e.g., viruses, the variant Creutzfeldt-Jakob disease (vCJD) agent and, theoretically, the Creutzfeldt-Jakob disease (CJD) agent.

What to do in case of emergency/overdose?[edit | edit source]

  • In case of overdose, call the poison control helpline of your country. In the United States, call 1-800-222-1222.

Can this medicine be used in pregnancy?[edit | edit source]

  • There are no data with EVARREST® use in pregnant women to inform a drug-associated risk.
  • It is not known whether EVARREST can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity.
  • EVARREST should be applied to a pregnant woman only if clearly needed.

Can this medicine be used in children?[edit | edit source]

  • Safety and effectiveness in pediatric patients have not been established.

What are the active and inactive ingredients in this medicine?[edit | edit source]

Active ingredients:

  • Fibrinogen Human
  • Human Thrombin

Inactive ingredients:

  • Arginine hydrochloride
  • Calcium chloride
  • Glycine
  • Albumin Human
  • Mannitol
  • Sodium acetate
  • Sodium chloride
  • Sodium citrate, unspecified form

Who manufactures and distributes this medicine?[edit | edit source]

Distributed by: Ethicon, Inc. Route 22 West, PO Box 151 Somerville, NJ USA

Manufactured by: Omrix Biopharmaceuticals Ltd. 14 Einstein Street Weizmann Science Park Nes-Ziona, Israel

What should I know about storage and disposal of this medication?[edit | edit source]

  • Use EVARREST before the expiration date indicated on the carton.
  • Store unopened packages of EVARREST at 2 to 25°C. EVARREST does not require refrigeration. Do not freeze.
  • Do not use if package is opened or damaged.
  • Once opened, keep EVARREST dry to avoid activation of the biological components prior to use.
Evarrest Resources
Doctor showing form.jpg

Translate to: East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski

Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD